The Interventional Oncology Center

Filter Your Results

 

News

 

Small Comparative Study Finds Patients Prefer Transradial Access Over Transfemoral Access

February 28, 2019 -- A recently published study found that patients favored transradial access (TRA) over transfemoral access (TFA) after experiencing both during the research…

Identifying the Right Diagnosis at the Right Time

Bruce H. Gray, DO, FSCAI, MSVM

January 2019—An interactive case study intended to emphasize the basics of medical diagnosis.

Vascular Coding Updates for 2019

Katharine L. Krol, MD, FSIR, FACR

January 2019—Changes to the interventional CPT codes for 2019 and how they will affect your practice.

Merit Medical Receives FDA Clearance for EmboCube Embolization Gelatin

November 29, 2018 -- Merit Medical Systems, Inc. announced that it has received FDA 510(k) clearance for EmboCube embolization gelatin. EmboCube is indicated for use in emboli…

Boston Scientific Announces Agreement on Terms to Acquire BTG plc

November 20, 2018 -- Boston Scientific Corporation has reached an agreement on terms of a recommended offer to acquire BTG plc. According to a company announcement, the boards…

Applying Evidence in Interventional Oncology

Nadine Abi-Jaoudeh, MD; and Julius Chapiro, MD

October 2018— Interventional oncology is a rapidly growing field within interventional radiology that aspires to become one of the pillars of

Tumor Boards in Interventional Oncology

With Ghassan K. Abou-Alfa, MD; Justin D. Blasberg, MD; Frank C. Detterbeck, MD, FACS, FCCP; Dimitris Filippiadis, MD, PhD, EBIR; Ryan Hickey, MD; Howard S. Hochster, MD; Zeljka Jutric, MD; Alexis Kelekis, MD, PhD, EBIR, FSIR; Maureen P. Kohi, MD, FSIR; Alexander Lam, MD; Robert J. Lewandowski, MD, FSIR; Areo Saffarzadeh, MD, MS; Mansi R. Shah, MD; Ronald F. Wolf, MD; Emi J. Yoshida, MD; and Etay Ziv, MD, PhD

October 2018—A multidisciplinary discussion of the approach to treatment for four patients with cancers of varying origins and severities.

Commentary: Staying on Course

Nadine Abi-Jaoudeh, MD

October 2018—Obtaining the highest level of evidence in interventional oncology requires that we stay on course and strive for positive prospective randomized trials.

 

advertisement

US Device Guide

The Endovascular Today Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.